Review
Copyright ©The Author(s) 2018.
World J Clin Cases. Oct 26, 2018; 6(12): 493-500
Published online Oct 26, 2018. doi: 10.12998/wjcc.v6.i12.493
Table 4 Composite of allogeneic bone marrow derived stem cell therapy trials
AuthorYear of studyFistula siteStudy populationMethod of administrationHealing type of fistula (unhealed, partially, fully)SafetyOutcome
Molendijk et al[1]2015Perianal21Patients assigned to four groups with curettage then intralesional fistula tract injection with stem cells or placebo (1) 1 × 107 (2) 3 × 107 (3) 9 ×107 (4) placeboWeek 24 fistula healing for groups (1) 66.7% (n = 5) (2) 85.7% (n = 5) (3) 28.6% (n = 5) (4) 33.3% (n = 6)All patients reported pain and pus and/or discharge from fistula for 1 wk postoperatively One patient in each group (1, 2, 3, and placebo) developed perianal abscessUse of intralesional injections of 3 × 107 was successful in fistula healing.